Le groupe Casino annonce la suppression de 42 emplois au siège de Franprix dans le Val-de-Marne
La direction de Franprix a annoncé la suppression d'une quarantaine de postes en région parisienne, mercredi 5 février 2025.
Ouest-France15d
Un adolescent de 17 ans tué dans un accident à Vitry-sur-Seine, la police recherche des témoins
Les policiers du commissariat de Vitry-sur-Seine ont lancé un appel à témoins après un accident de la route mortel, survenu fin décembre 2024. Un piéton de 17 ans avait été fauché par ...
Benzinga.com23d
Sanofi Genzyme Facility Draws FDA Criticism Over Alleged Quality Lapses
Also Read: Sanofi’s Blood Cancer Drug’s New Subcutaneous Formulation Hits Primary Goal In Late-Stage In Multiple Myeloma The facility’s quality unit was also scrutinized for its inability to ...
The Business Journals24d
Sanofi’s Framingham facility hit with FDA warning
French pharmaceutical giant Sanofi has received a warning letter from the U.S. Food and Drug Administration following an inspection at its drug manufacturing facility in Framingham. French ...
Seeking Alpha24d
Sanofi says FDA lifted clinical hold on trial for Cialis OTC switch
Sanofi’s (NASDAQ:SNY) consumer healthcare unit Opella announced Tuesday that the U.S. FDA has lifted a clinical hold on a trial designed to test an over-the-counter version of its erectile ...
FiercePharma24d
Sanofi API plant hit with FDA warning letter detailing quality, consistency flubs
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a U.S. drug ingredients plant tied to its longstanding subsidiary Genzyme.
FiercePharma24d
Sanofi's consumer health arm Opella secures FDA green light to pursue OTC Cialis study
In 2014, Lilly inked a licensing agreement with Sanofi that allows the latter company to pursue regulatory approval of OTC Cialis in the U.S., Europe, Canada and Australia.
Business Insider25d
Sanofi's Opella: FDA Lifts Clinical Hold On OTC Cialis Trial
(RTTNews) - Sanofi's Consumer Healthcare division, Opella, announced that the U.S. Food and Drug Administration has lifted a clinical hold on its planned actual use trial (AUT). The trial is aimed ...
STAT25d
Sanofi is warned by the FDA over ‘significant’ problems at a key manufacturing plant
The Food and Drug Administration has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility in Massachusetts where the company makes ...
La Voix du Nord25d
Vitry-en-Artois (Pas-de-Calais)
Une troisième cellule est en attente d’un acquéreur, un restaurant est espéré. Vitry-en-Artois : l’amicale des donneurs de sang a stabilisé son niveau de collecte Trois cent treize ...
Business Insider26d
Sanofi’s Growth Prospects and Undervalued Position Highlighted by Analyst Graham Parry
Sanofi (SNYNF – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Graham Parry from Bank of America Securities reiterated a Buy rating on the ...